Omeros reported $-22703000 in Net Income for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Acelrx Pharmaceuticals ACRX:US $ -8.38M 1.48M
Adamas Pharmaceuticals ADMS:US -19518000 7.17M
Adma Biologics ADMA:US $ -17.71M 1.19M
Aerie Pharmaceuticals AERI:US $ -39.69M 1M
Alexion Pharmaceuticals ALXN:US $ 636M 100.2M
Alnylam Pharmaceuticals ALNY:US $ -204.51M 14.96M
Biomarin Pharmaceutical BMRN:US $ -36.49M 49.44M
Cytokinetics CYTK:US $ -76.09M 14.53M
Gilead Sciences GILD:US $ 2592M 1070M
Insmed INSM:US $ -112714000 4.61M
Intercept Pharmaceuticals ICPT:US $ -3.63M 7.46M
Knight Therapeutics Inc GUD:CN C$ -8586000 37.59M
Macrogenics MGNX:US $ -52.89M 12.95M
Mirati Therapeutics MRTX:US $ -80.05M 86.38M
Omeros OMER:US $ -22703000 5.89M
Pacira Pharmaceuticals PCRX:US $ 17.66M 1.42M
Pfizer PFE:US $ 8146M 2582M
Rockwell Medical RMTI:US $ -7.58M 0.82M
Sangamo Biosciences SGMO:US $ -47.69M 0.52M
Sarepta Therapeutics SRPT:US $ -48.14M 33.26M
United Therapeutics UTHR:US $ 162.7M 9.9M
Vertex Pharmaceuticals VRTX:US $ 851.93M 785M
Xoma XOMA:US $ -4436000 2.2M